b6h12 2 Search Results


94
Novus Biologicals cd47
Cd47, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b6h12+2/pm37121366-98-33-35?v=Novus+Biologicals
Average 94 stars, based on 1 article reviews
cd47 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Novus Biologicals cd47 antibody
<t>CD47</t> (cluster of differentiation) mediates TSP1 (thrombospondin-1)-induced inhibition of lymphangiogenesis. A , Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to determine the relative mRNA levels of CD47 and CD36 in human lymphatic endothelial cells (HLECs) and human aortic endothelial cells (HAoEC). Bar graph represents mRNA levels in comparison to CD36 (n=9). B , Control and CD47 siRNA-treated lymphatic endothelial cells (LECs; 48 h) were utilized to quantify CD47 transcript expression using qRT-PCR (n=6). C , WST (water-soluble tetrazolium)-1 assay was conducted to investigate the effects of CD47 silencing on LEC proliferation in response to TSP1 treatment as described in Figure 2A. Data are representative of 3 independent experiments performed at least in quadruplicate. D , Control and CD47 -silenced LECs were used to evaluate cell migration. Scale bar, 200 µm. xBar graph represents the percentage of migrated cells (n=3–4). E through G , Control and CD47 -silenced cells were pretreated as in Figure 2D and seeded in wells of a Matrigel-coated plate in basal medium containing VEGF (vascular endothelial growth factor)-C±TSP1 and tube formation determined. Representative images of tube formation are shown ( E ). Scale bar, 1000 µm. Tube length ( F ) and number of branching points ( G ) quantified (n=7). H , Wild-type male mice were injected SC with Matrigel solutions premixed with either VEGF-C, VEGF-C+TSP1+IgG, or VEGF-C+TSP1+CD47-blocking antibody. Plugs were isolated after 10 days, sectioned, and immunostained for LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1). Representative images of LYVE-1 staining of the cross-sections of the Matrigel plugs and quantification of LYVE-1–positive area are shown (n=5–7). Scale bar, 20 μm. Statistical analyses were performed using 2-way ANOVA ( A , C , D , F , and G ) with Bonferroni ( A ), Tukey ( C , F , and G ), and Sidak ( D ) multiple comparisons test, 2-tailed unpaired Student t test ( B ), and Kruskal-Wallis test for multiple comparisons ( H ). Data represent mean±SEM.
Cd47 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b6h12+2/pmc10281185-47-0-3?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
cd47 antibody - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Novus Biologicals b6h12 2
<t>CD47</t> (cluster of differentiation) mediates TSP1 (thrombospondin-1)-induced inhibition of lymphangiogenesis. A , Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to determine the relative mRNA levels of CD47 and CD36 in human lymphatic endothelial cells (HLECs) and human aortic endothelial cells (HAoEC). Bar graph represents mRNA levels in comparison to CD36 (n=9). B , Control and CD47 siRNA-treated lymphatic endothelial cells (LECs; 48 h) were utilized to quantify CD47 transcript expression using qRT-PCR (n=6). C , WST (water-soluble tetrazolium)-1 assay was conducted to investigate the effects of CD47 silencing on LEC proliferation in response to TSP1 treatment as described in Figure 2A. Data are representative of 3 independent experiments performed at least in quadruplicate. D , Control and CD47 -silenced LECs were used to evaluate cell migration. Scale bar, 200 µm. xBar graph represents the percentage of migrated cells (n=3–4). E through G , Control and CD47 -silenced cells were pretreated as in Figure 2D and seeded in wells of a Matrigel-coated plate in basal medium containing VEGF (vascular endothelial growth factor)-C±TSP1 and tube formation determined. Representative images of tube formation are shown ( E ). Scale bar, 1000 µm. Tube length ( F ) and number of branching points ( G ) quantified (n=7). H , Wild-type male mice were injected SC with Matrigel solutions premixed with either VEGF-C, VEGF-C+TSP1+IgG, or VEGF-C+TSP1+CD47-blocking antibody. Plugs were isolated after 10 days, sectioned, and immunostained for LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1). Representative images of LYVE-1 staining of the cross-sections of the Matrigel plugs and quantification of LYVE-1–positive area are shown (n=5–7). Scale bar, 20 μm. Statistical analyses were performed using 2-way ANOVA ( A , C , D , F , and G ) with Bonferroni ( A ), Tukey ( C , F , and G ), and Sidak ( D ) multiple comparisons test, 2-tailed unpaired Student t test ( B ), and Kruskal-Wallis test for multiple comparisons ( H ). Data represent mean±SEM.
B6h12 2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b6h12+2/pmc08700718-119-38-40?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
b6h12 2 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Novus Biologicals alexafluortm 405
<t>CD47</t> (cluster of differentiation) mediates TSP1 (thrombospondin-1)-induced inhibition of lymphangiogenesis. A , Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to determine the relative mRNA levels of CD47 and CD36 in human lymphatic endothelial cells (HLECs) and human aortic endothelial cells (HAoEC). Bar graph represents mRNA levels in comparison to CD36 (n=9). B , Control and CD47 siRNA-treated lymphatic endothelial cells (LECs; 48 h) were utilized to quantify CD47 transcript expression using qRT-PCR (n=6). C , WST (water-soluble tetrazolium)-1 assay was conducted to investigate the effects of CD47 silencing on LEC proliferation in response to TSP1 treatment as described in Figure 2A. Data are representative of 3 independent experiments performed at least in quadruplicate. D , Control and CD47 -silenced LECs were used to evaluate cell migration. Scale bar, 200 µm. xBar graph represents the percentage of migrated cells (n=3–4). E through G , Control and CD47 -silenced cells were pretreated as in Figure 2D and seeded in wells of a Matrigel-coated plate in basal medium containing VEGF (vascular endothelial growth factor)-C±TSP1 and tube formation determined. Representative images of tube formation are shown ( E ). Scale bar, 1000 µm. Tube length ( F ) and number of branching points ( G ) quantified (n=7). H , Wild-type male mice were injected SC with Matrigel solutions premixed with either VEGF-C, VEGF-C+TSP1+IgG, or VEGF-C+TSP1+CD47-blocking antibody. Plugs were isolated after 10 days, sectioned, and immunostained for LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1). Representative images of LYVE-1 staining of the cross-sections of the Matrigel plugs and quantification of LYVE-1–positive area are shown (n=5–7). Scale bar, 20 μm. Statistical analyses were performed using 2-way ANOVA ( A , C , D , F , and G ) with Bonferroni ( A ), Tukey ( C , F , and G ), and Sidak ( D ) multiple comparisons test, 2-tailed unpaired Student t test ( B ), and Kruskal-Wallis test for multiple comparisons ( H ). Data represent mean±SEM.
Alexafluortm 405, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b6h12+2/pmc12066502-5-4-7?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
alexafluortm 405 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

91
ATCC b6h12 2 hybridoma
<t>CD47</t> (cluster of differentiation) mediates TSP1 (thrombospondin-1)-induced inhibition of lymphangiogenesis. A , Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to determine the relative mRNA levels of CD47 and CD36 in human lymphatic endothelial cells (HLECs) and human aortic endothelial cells (HAoEC). Bar graph represents mRNA levels in comparison to CD36 (n=9). B , Control and CD47 siRNA-treated lymphatic endothelial cells (LECs; 48 h) were utilized to quantify CD47 transcript expression using qRT-PCR (n=6). C , WST (water-soluble tetrazolium)-1 assay was conducted to investigate the effects of CD47 silencing on LEC proliferation in response to TSP1 treatment as described in Figure 2A. Data are representative of 3 independent experiments performed at least in quadruplicate. D , Control and CD47 -silenced LECs were used to evaluate cell migration. Scale bar, 200 µm. xBar graph represents the percentage of migrated cells (n=3–4). E through G , Control and CD47 -silenced cells were pretreated as in Figure 2D and seeded in wells of a Matrigel-coated plate in basal medium containing VEGF (vascular endothelial growth factor)-C±TSP1 and tube formation determined. Representative images of tube formation are shown ( E ). Scale bar, 1000 µm. Tube length ( F ) and number of branching points ( G ) quantified (n=7). H , Wild-type male mice were injected SC with Matrigel solutions premixed with either VEGF-C, VEGF-C+TSP1+IgG, or VEGF-C+TSP1+CD47-blocking antibody. Plugs were isolated after 10 days, sectioned, and immunostained for LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1). Representative images of LYVE-1 staining of the cross-sections of the Matrigel plugs and quantification of LYVE-1–positive area are shown (n=5–7). Scale bar, 20 μm. Statistical analyses were performed using 2-way ANOVA ( A , C , D , F , and G ) with Bonferroni ( A ), Tukey ( C , F , and G ), and Sidak ( D ) multiple comparisons test, 2-tailed unpaired Student t test ( B ), and Kruskal-Wallis test for multiple comparisons ( H ). Data represent mean±SEM.
B6h12 2 Hybridoma, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b6h12+2/pmc13049245-52-6-8?v=ATCC
Average 91 stars, based on 1 article reviews
b6h12 2 hybridoma - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

92
Biotium cf 640r conjugated mouse anti human cd47 ab
<t>CD47</t> (cluster of differentiation) mediates TSP1 (thrombospondin-1)-induced inhibition of lymphangiogenesis. A , Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to determine the relative mRNA levels of CD47 and CD36 in human lymphatic endothelial cells (HLECs) and human aortic endothelial cells (HAoEC). Bar graph represents mRNA levels in comparison to CD36 (n=9). B , Control and CD47 siRNA-treated lymphatic endothelial cells (LECs; 48 h) were utilized to quantify CD47 transcript expression using qRT-PCR (n=6). C , WST (water-soluble tetrazolium)-1 assay was conducted to investigate the effects of CD47 silencing on LEC proliferation in response to TSP1 treatment as described in Figure 2A. Data are representative of 3 independent experiments performed at least in quadruplicate. D , Control and CD47 -silenced LECs were used to evaluate cell migration. Scale bar, 200 µm. xBar graph represents the percentage of migrated cells (n=3–4). E through G , Control and CD47 -silenced cells were pretreated as in Figure 2D and seeded in wells of a Matrigel-coated plate in basal medium containing VEGF (vascular endothelial growth factor)-C±TSP1 and tube formation determined. Representative images of tube formation are shown ( E ). Scale bar, 1000 µm. Tube length ( F ) and number of branching points ( G ) quantified (n=7). H , Wild-type male mice were injected SC with Matrigel solutions premixed with either VEGF-C, VEGF-C+TSP1+IgG, or VEGF-C+TSP1+CD47-blocking antibody. Plugs were isolated after 10 days, sectioned, and immunostained for LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1). Representative images of LYVE-1 staining of the cross-sections of the Matrigel plugs and quantification of LYVE-1–positive area are shown (n=5–7). Scale bar, 20 μm. Statistical analyses were performed using 2-way ANOVA ( A , C , D , F , and G ) with Bonferroni ( A ), Tukey ( C , F , and G ), and Sidak ( D ) multiple comparisons test, 2-tailed unpaired Student t test ( B ), and Kruskal-Wallis test for multiple comparisons ( H ). Data represent mean±SEM.
Cf 640r Conjugated Mouse Anti Human Cd47 Ab, supplied by Biotium, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/b6h12+2/pm39712032-97-12-20?v=Biotium
Average 92 stars, based on 1 article reviews
cf 640r conjugated mouse anti human cd47 ab - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

N/A
The CD47 Antibody IAP 964 B6H12 2 Azide and BSA Free from Novus Biologicals is a mouse monoclonal antibody to CD47 This antibody reacts with human mouse The CD47 Antibody IAP 964 B6H12 2 Azide
  Buy from Supplier

N/A
The CD47 Antibody IAP 964 B6H12 2 from Novus Biologicals is a mouse monoclonal antibody to CD47 This antibody reacts with human mouse The CD47 Antibody IAP 964 B6H12 2 has been validated for the
  Buy from Supplier

Image Search Results


CD47 (cluster of differentiation) mediates TSP1 (thrombospondin-1)-induced inhibition of lymphangiogenesis. A , Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to determine the relative mRNA levels of CD47 and CD36 in human lymphatic endothelial cells (HLECs) and human aortic endothelial cells (HAoEC). Bar graph represents mRNA levels in comparison to CD36 (n=9). B , Control and CD47 siRNA-treated lymphatic endothelial cells (LECs; 48 h) were utilized to quantify CD47 transcript expression using qRT-PCR (n=6). C , WST (water-soluble tetrazolium)-1 assay was conducted to investigate the effects of CD47 silencing on LEC proliferation in response to TSP1 treatment as described in Figure 2A. Data are representative of 3 independent experiments performed at least in quadruplicate. D , Control and CD47 -silenced LECs were used to evaluate cell migration. Scale bar, 200 µm. xBar graph represents the percentage of migrated cells (n=3–4). E through G , Control and CD47 -silenced cells were pretreated as in Figure 2D and seeded in wells of a Matrigel-coated plate in basal medium containing VEGF (vascular endothelial growth factor)-C±TSP1 and tube formation determined. Representative images of tube formation are shown ( E ). Scale bar, 1000 µm. Tube length ( F ) and number of branching points ( G ) quantified (n=7). H , Wild-type male mice were injected SC with Matrigel solutions premixed with either VEGF-C, VEGF-C+TSP1+IgG, or VEGF-C+TSP1+CD47-blocking antibody. Plugs were isolated after 10 days, sectioned, and immunostained for LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1). Representative images of LYVE-1 staining of the cross-sections of the Matrigel plugs and quantification of LYVE-1–positive area are shown (n=5–7). Scale bar, 20 μm. Statistical analyses were performed using 2-way ANOVA ( A , C , D , F , and G ) with Bonferroni ( A ), Tukey ( C , F , and G ), and Sidak ( D ) multiple comparisons test, 2-tailed unpaired Student t test ( B ), and Kruskal-Wallis test for multiple comparisons ( H ). Data represent mean±SEM.

Journal: Arteriosclerosis, Thrombosis, and Vascular Biology

Article Title: CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis

doi: 10.1161/ATVBAHA.122.318904

Figure Lengend Snippet: CD47 (cluster of differentiation) mediates TSP1 (thrombospondin-1)-induced inhibition of lymphangiogenesis. A , Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to determine the relative mRNA levels of CD47 and CD36 in human lymphatic endothelial cells (HLECs) and human aortic endothelial cells (HAoEC). Bar graph represents mRNA levels in comparison to CD36 (n=9). B , Control and CD47 siRNA-treated lymphatic endothelial cells (LECs; 48 h) were utilized to quantify CD47 transcript expression using qRT-PCR (n=6). C , WST (water-soluble tetrazolium)-1 assay was conducted to investigate the effects of CD47 silencing on LEC proliferation in response to TSP1 treatment as described in Figure 2A. Data are representative of 3 independent experiments performed at least in quadruplicate. D , Control and CD47 -silenced LECs were used to evaluate cell migration. Scale bar, 200 µm. xBar graph represents the percentage of migrated cells (n=3–4). E through G , Control and CD47 -silenced cells were pretreated as in Figure 2D and seeded in wells of a Matrigel-coated plate in basal medium containing VEGF (vascular endothelial growth factor)-C±TSP1 and tube formation determined. Representative images of tube formation are shown ( E ). Scale bar, 1000 µm. Tube length ( F ) and number of branching points ( G ) quantified (n=7). H , Wild-type male mice were injected SC with Matrigel solutions premixed with either VEGF-C, VEGF-C+TSP1+IgG, or VEGF-C+TSP1+CD47-blocking antibody. Plugs were isolated after 10 days, sectioned, and immunostained for LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1). Representative images of LYVE-1 staining of the cross-sections of the Matrigel plugs and quantification of LYVE-1–positive area are shown (n=5–7). Scale bar, 20 μm. Statistical analyses were performed using 2-way ANOVA ( A , C , D , F , and G ) with Bonferroni ( A ), Tukey ( C , F , and G ), and Sidak ( D ) multiple comparisons test, 2-tailed unpaired Student t test ( B ), and Kruskal-Wallis test for multiple comparisons ( H ). Data represent mean±SEM.

Article Snippet: CD47 antibody (NBP2-31106; Novus Biologicals, LLC, Centennial, CO) and ab175388 (Abcam, Cambridge, MA) were used.

Techniques: Inhibition, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Comparison, Control, Expressing, Migration, Injection, Blocking Assay, Isolation, Staining

TSP1 (thrombospondin-1)-induced CD47 (cluster of differentiation) activation blocks VEGF (vascular endothelial growth factor)-C–stimulated lymphangiogenic signaling. A through D , Lymphatic endothelial cells (LECs) were pretreated with TSP1 (22 nM, 16 h) in 0.5% fetal bovine serum (FBS) containing basal media MV2, stimulated with VEGF-C (15 min), and cell lysates subjected to Western blot analysis. A , Representative Western blot images are shown. B through D , Bar diagrams represent mean protein levels expressed as a ratio of phospho-to-total proteins, AKT ( B ), eNOS ( C ), and ERK1/2 ( D ; n=3). E , LECs were treated with control or CD47 -siRNA (48 h) and immunoblotting done to determine CD47 expression (ab175388). F through I , Control or CD47 -siRNA–treated cells were treated as in Figure 4A and Western blot experiments executed. F , Representative Western blot images are shown. G through I , Bar diagrams represent pAKT/total AKT ( G ), peNOS/total eNOS ( H ), and pERK1/2/total ERK1/2 ( I ; n=3). J , Control or CD47 -silenced LECs were pretreated with TSP1 (22 nM, 4 h), stimulated with VEGF-C (100 ng/mL, 1 h) and analyzed for NO (nitric oxide) production using DAF-FM diacetate. K , Control or CD47 -silenced LECs were pretreated with vehicle or TSP1 (1 h), incubated with H2DCFDA solution, and fluorescence analyzed using flow cytometry. Statistical analyses were performed using 1-way ANOVA ( B–D ), 2-way ANOVA with Tukey test for multiple comparisons ( G–I and K ), and 2-tailed unpaired Student t test ( J ). Data represent mean±SEM.

Journal: Arteriosclerosis, Thrombosis, and Vascular Biology

Article Title: CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis

doi: 10.1161/ATVBAHA.122.318904

Figure Lengend Snippet: TSP1 (thrombospondin-1)-induced CD47 (cluster of differentiation) activation blocks VEGF (vascular endothelial growth factor)-C–stimulated lymphangiogenic signaling. A through D , Lymphatic endothelial cells (LECs) were pretreated with TSP1 (22 nM, 16 h) in 0.5% fetal bovine serum (FBS) containing basal media MV2, stimulated with VEGF-C (15 min), and cell lysates subjected to Western blot analysis. A , Representative Western blot images are shown. B through D , Bar diagrams represent mean protein levels expressed as a ratio of phospho-to-total proteins, AKT ( B ), eNOS ( C ), and ERK1/2 ( D ; n=3). E , LECs were treated with control or CD47 -siRNA (48 h) and immunoblotting done to determine CD47 expression (ab175388). F through I , Control or CD47 -siRNA–treated cells were treated as in Figure 4A and Western blot experiments executed. F , Representative Western blot images are shown. G through I , Bar diagrams represent pAKT/total AKT ( G ), peNOS/total eNOS ( H ), and pERK1/2/total ERK1/2 ( I ; n=3). J , Control or CD47 -silenced LECs were pretreated with TSP1 (22 nM, 4 h), stimulated with VEGF-C (100 ng/mL, 1 h) and analyzed for NO (nitric oxide) production using DAF-FM diacetate. K , Control or CD47 -silenced LECs were pretreated with vehicle or TSP1 (1 h), incubated with H2DCFDA solution, and fluorescence analyzed using flow cytometry. Statistical analyses were performed using 1-way ANOVA ( B–D ), 2-way ANOVA with Tukey test for multiple comparisons ( G–I and K ), and 2-tailed unpaired Student t test ( J ). Data represent mean±SEM.

Article Snippet: CD47 antibody (NBP2-31106; Novus Biologicals, LLC, Centennial, CO) and ab175388 (Abcam, Cambridge, MA) were used.

Techniques: Activation Assay, Western Blot, Control, Expressing, Incubation, Fluorescence, Flow Cytometry

Lymphatic endothelial cell (LEC)–specific Cd47 deficiency reduces atherosclerotic lesion formation. A through M , Male Cd47 WT and Cd47 ΔLEC mice were injected with AAV (adeno-associated virus) 8- PCSK9 IP, fed a Western diet for 16 weeks and atherosclerosis analyzed. A , Representative in situ images of aortic arch (yellow arrowheads point to atherosclerotic lesions). Scale bar, 2 mm. B , Representative en face oil red O (ORO) staining of aorta. Scale bar, 5 mm. C , Quantification of plaque area in aorta (n=13–14). D through G , Bar diagrams show plasma total cholesterol ( D ), plasma triglycerides ( E ), fasting blood glucose levels ( F ), and body composition (fat, lean, and fluid mass; G ; n=8–13). H , Representative images of aortic root cross-sections stained with H&E (neointima area), ORO (lipid accumulation), Masson trichrome (collagen content), CD68 (cluster of differentiation; macrophage burden), and necrotic area (encircled in red). Scale bar, 200 µm. I through M , Bar diagrams show neointima area ( I ), lipid deposition ( J ), collagen content ( K ), macrophage accumulation ( L ), and necrotic area ( M ) in aortic root sections (n=5–9). Statistical analyses were performed using a 2-tailed unpaired Mann-Whitney U test ( C , E , and M ), 2-tailed unpaired Student t test ( D , F , and I–L ), and 2-way ANOVA followed by Sidak post hoc test ( G ). Data represent mean±SEM.

Journal: Arteriosclerosis, Thrombosis, and Vascular Biology

Article Title: CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis

doi: 10.1161/ATVBAHA.122.318904

Figure Lengend Snippet: Lymphatic endothelial cell (LEC)–specific Cd47 deficiency reduces atherosclerotic lesion formation. A through M , Male Cd47 WT and Cd47 ΔLEC mice were injected with AAV (adeno-associated virus) 8- PCSK9 IP, fed a Western diet for 16 weeks and atherosclerosis analyzed. A , Representative in situ images of aortic arch (yellow arrowheads point to atherosclerotic lesions). Scale bar, 2 mm. B , Representative en face oil red O (ORO) staining of aorta. Scale bar, 5 mm. C , Quantification of plaque area in aorta (n=13–14). D through G , Bar diagrams show plasma total cholesterol ( D ), plasma triglycerides ( E ), fasting blood glucose levels ( F ), and body composition (fat, lean, and fluid mass; G ; n=8–13). H , Representative images of aortic root cross-sections stained with H&E (neointima area), ORO (lipid accumulation), Masson trichrome (collagen content), CD68 (cluster of differentiation; macrophage burden), and necrotic area (encircled in red). Scale bar, 200 µm. I through M , Bar diagrams show neointima area ( I ), lipid deposition ( J ), collagen content ( K ), macrophage accumulation ( L ), and necrotic area ( M ) in aortic root sections (n=5–9). Statistical analyses were performed using a 2-tailed unpaired Mann-Whitney U test ( C , E , and M ), 2-tailed unpaired Student t test ( D , F , and I–L ), and 2-way ANOVA followed by Sidak post hoc test ( G ). Data represent mean±SEM.

Article Snippet: CD47 antibody (NBP2-31106; Novus Biologicals, LLC, Centennial, CO) and ab175388 (Abcam, Cambridge, MA) were used.

Techniques: Injection, Virus, Western Blot, In Situ, Staining, Clinical Proteomics, MANN-WHITNEY

Lymphatic endothelial cell (LEC)–specific deletion of Cd47 (cluster of differentiation) in mice increases arterial lymphatic vessel (LV) density. A through D , Aortic root cross-sections from male AAV (adeno-associated virus) 8- PCSK9 –injected Cd47 WT and Cd47 ΔLEC mice (16-wk Western diet) were immunostained for CD68, iNOS (inducible NO [nitric oxide] synthase), Arg1 (arginase 1), and LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1). Nuclei were counterstained with DAPI (4’,6-diamidino-2-phenylindole; blue). Representative confocal images of iNOS (green; A ) and CD68 (red); Arg1 (green; B ) and CD68 (red; scale bar, 50 µm); and LYVE-1 staining (red; C ; scale bar, 20 µm) are shown (n=5–6). Statistical analyses were performed using a 2-tailed unpaired Student t test ( A and B ) and a Mann-Whitney U test ( C ). Data represent mean±SEM. A indicates adventitia; M, media; and P, plaque.

Journal: Arteriosclerosis, Thrombosis, and Vascular Biology

Article Title: CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis

doi: 10.1161/ATVBAHA.122.318904

Figure Lengend Snippet: Lymphatic endothelial cell (LEC)–specific deletion of Cd47 (cluster of differentiation) in mice increases arterial lymphatic vessel (LV) density. A through D , Aortic root cross-sections from male AAV (adeno-associated virus) 8- PCSK9 –injected Cd47 WT and Cd47 ΔLEC mice (16-wk Western diet) were immunostained for CD68, iNOS (inducible NO [nitric oxide] synthase), Arg1 (arginase 1), and LYVE-1 (lymphatic vessel endothelial hyaluronan receptor-1). Nuclei were counterstained with DAPI (4’,6-diamidino-2-phenylindole; blue). Representative confocal images of iNOS (green; A ) and CD68 (red); Arg1 (green; B ) and CD68 (red; scale bar, 50 µm); and LYVE-1 staining (red; C ; scale bar, 20 µm) are shown (n=5–6). Statistical analyses were performed using a 2-tailed unpaired Student t test ( A and B ) and a Mann-Whitney U test ( C ). Data represent mean±SEM. A indicates adventitia; M, media; and P, plaque.

Article Snippet: CD47 antibody (NBP2-31106; Novus Biologicals, LLC, Centennial, CO) and ab175388 (Abcam, Cambridge, MA) were used.

Techniques: Virus, Injection, Western Blot, Staining, MANN-WHITNEY